跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,968 条关于
“Avista Therapeutics”
全部
16,968
临床试验
3,800
药物
3,131
机构
1,162
资讯
8,875
去年
Avista Therapeutics Partners with Forge Biologics to Advance AVST-101 Gene Therapy for X-linked Retinoschisis
9个月前
Cosette Pharmaceuticals Launches First Generic CIPRO HC with 180-Day Market Exclusivity
去年
Highridge Medical Divests Bone Healing Division to Focus on Core Spine Technologies
3天前
Avacta Reports Clinical Proof of Mechanism for FAP-Activated Exatecan PDC AVA6103 in Phase 1 FOCUS-01
8个月前
Acuitas Therapeutics Acquires Majority Stake in RNA Technologies & Therapeutics to Advance RNA-LNP Therapeutics
去年
Avacta Completes Transition to Pure-Play Therapeutics with £2.2M Coris Sale
6个月前
Percheron Therapeutics Raises $2.2 Million to Advance VISTA-Targeting Cancer Therapy HMBD-002
3个月前
XRHealth Acquires Swing Therapeutics to Expand Digital Therapeutics Portfolio
7个月前
Rapid Dose Therapeutics Launches QuickStrip Medical Cannabis in Brazil Following ANVISA Approval
上个月
BioMarin acquires Alesta Therapeutics and its hypophosphatasia drug ALE1 in $275M deal
第 1 页,共 888 页
上一页
下一页